{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:18Z","timestamp":1792112298660,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NUI Galway Millennium Fund"},{"name":"Physiology and Pharmacology and Therapeutics, NUI Galway, Ireland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.bbr.2013.04.043","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T18:47:10Z","timestamp":1367434030000},"page":"124-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"special_numbering":"C","title":["Alterations in the endocannabinoid system in the rat valproic acid model of autism"],"prefix":"10.1016","volume":"249","author":[{"given":"D.M.","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Conboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.P.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.04.043_bib0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","article-title":"A male with fetal valproate syndrome and autism","volume":"39","author":"Williams","year":"1997","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1017\/S001216220100038X","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0020","first-page":"531","article-title":"Nociceptive changes in rats after prenatal exposure to valproic acid","volume":"53","author":"Schneider","year":"2001","journal-title":"Polish Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0795-y","article-title":"Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism","volume":"193","author":"Schneider","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","article-title":"Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism","volume":"22","author":"Ingram","year":"2000","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0890-6238(97)80001-U","article-title":"Linking etiologies in humans and animal models: studies of autism","volume":"11","author":"Rodier","year":"1997","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.brainresbull.2012.01.011","article-title":"Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories","volume":"87","author":"Sui","year":"2012","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.bbr.2013.04.043_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Frontiers in Neural Circuits"},{"key":"10.1016\/j.bbr.2013.04.043_bib0060","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory postsynaptic development and social interaction in prenatal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.bbr.2013.04.043_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2009.12.054","article-title":"Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism","volume":"470","author":"Dufour-Rainfray","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbr.2013.04.043_bib0070","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2008.12.001","article-title":"Endocannabinoid signals in the control of emotion","volume":"9","author":"Lutz","year":"2009","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/52908","article-title":"Endocannabinoid system and synaptic plasticity: implications for emotional responses","volume":"2007","author":"Viveros","year":"2007","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.bbr.2013.04.043_bib0085","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"Hogestatt","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.bbr.2013.04.043_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.55782\/ane-2010-1793","article-title":"Can autism be triggered by acetaminophen activation of the endocannabinoid system?","volume":"70","author":"Schultz","year":"2010","journal-title":"Acta Neurobiologiae Experimentalis (Warsaw)"},{"key":"10.1016\/j.bbr.2013.04.043_bib0095","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1460-9568.2006.04697.x","article-title":"Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces","volume":"23","author":"Chakrabarti","year":"2006","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.04.043_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-2-10","article-title":"Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces","volume":"2","author":"Chakrabarti","year":"2011","journal-title":"Molecular Autism"},{"key":"10.1016\/j.bbr.2013.04.043_bib0105","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","article-title":"Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats","volume":"32","author":"Trezza","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.04.043_bib0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2011.01.044","article-title":"Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system","volume":"220","author":"Marco","year":"2011","journal-title":"Behavioral Brain Research"},{"issue":"Pt 1","key":"10.1016\/j.bbr.2013.04.043_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj3310015","article-title":"The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide","volume":"331","author":"Di Marzo","year":"1998","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.bbr.2013.04.043_bib0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-007-1025-3","article-title":"Bidirectional cannabinoid modulation of social behavior in adolescent rats","volume":"197","author":"Trezza","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2009.06.020","article-title":"Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors","volume":"33","author":"Umathe","year":"2009","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.04.043_bib0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","article-title":"Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice","volume":"38","author":"Gould","year":"2012","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.04.043_bib0135","doi-asserted-by":"crossref","unstructured":"Meyza, K.Z., Defensor, E.B., Jensen, A.L., Corley, M.J., Pearson, B.L., Pobbe, R.L., et al. The BTBR T(+)tf\/J mouse model for autism spectrum disorders-in search of biomarkers. Behavioral Brain Research, http:\/\/dx.doi.org\/10.1016\/j.bbr.2012.07.021, in press.","DOI":"10.1016\/j.bbr.2012.07.021"},{"key":"10.1016\/j.bbr.2013.04.043_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157015911795017047","article-title":"Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders","volume":"9","author":"Onaivi","year":"2011","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0145","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of United States of America"},{"key":"10.1016\/j.bbr.2013.04.043_bib0150","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.04.043_bib0155","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/npp.2010.19","article-title":"Abnormal mGlu 5 receptor\/endocannabinoid coupling in mice lacking FMRP and BC1 RNA","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nature Communications"},{"key":"10.1016\/j.bbr.2013.04.043_bib0165","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1042\/BST0341095","article-title":"Cannabinoids and PPARalpha signalling","volume":"34","author":"Sun","year":"2006","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.bbr.2013.04.043_bib0170","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0175","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11064-012-0717-1","article-title":"Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats","volume":"37","author":"Sandhya","year":"2012","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.bbr.2013.04.043_bib0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Mental Retardation and Developmental Disabilities Research Reviews"},{"key":"10.1016\/j.bbr.2013.04.043_bib0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1601-183X.2004.00071.x","article-title":"Automated apparatus for quantitation of social approach behaviors in mice","volume":"3","author":"Nadler","year":"2004","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/j.bbr.2013.04.043_bib0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2011.09.032","article-title":"Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor","volume":"1","author":"Kerr","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2013.04.043_bib0195","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/j.1476-5381.2011.01478.x","article-title":"The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone","volume":"165","author":"Olango","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0200","unstructured":"Kerr, D.M., Harhan, B., Okine, B.N., Egan, L.J., Finn, D.P., Roche, M. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. British Journal of Pharmacology, http:\/\/dx.doi.org\/10.1111\/j.1476-5381.2012.02237, in press."},{"key":"10.1016\/j.bbr.2013.04.043_bib0205","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.pain.2011.07.014","article-title":"A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats","volume":"152","author":"Ford","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.bbr.2013.04.043_bib0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-511X-10-129","article-title":"The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans","volume":"10","author":"Cable","year":"2011","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.bbr.2013.04.043_bib0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.bbr.2013.04.043_bib0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.fct.2012.10.011","article-title":"Effects of Korean red ginseng extracts on neural tube defects and impairment of social interaction induced by prenatal exposure to valproic acid","volume":"51","author":"Kim","year":"2013","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0225","first-page":"394","article-title":"Pain reactivity in children with autistic disorder","volume":"44","author":"Militerni","year":"2000","journal-title":"Journal of the Intellectual Disability Research"},{"key":"10.1016\/j.bbr.2013.04.043_bib0230","doi-asserted-by":"crossref","first-page":"e5289","DOI":"10.1371\/journal.pone.0005289","article-title":"Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder","volume":"4","author":"Tordjman","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2013.04.043_bib0235","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11064-012-0724-2","article-title":"Downregulating the canonical Wnt\/beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.bbr.2013.04.043_bib0240","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2051-0","article-title":"Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice","volume":"214","author":"Cassano","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.04.043_bib0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/jpet.108.141069","article-title":"Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats","volume":"328","author":"Trezza","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.04.043_bib0250","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jnr.22580","article-title":"Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex","volume":"89","author":"Zenko","year":"2011","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.bbr.2013.04.043_bib0255","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neubiorev.2005.12.002","article-title":"Cannabinoids and prefrontal cortical function: insights from preclinical studies","volume":"30","author":"Egerton","year":"2006","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.bbr.2013.04.043_bib0260","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1523\/JNEUROSCI.2153-12.2012","article-title":"Cognitive enhancement with rosiglitazone links the hippocampal PPARgamma and ERK MAPK signaling pathways","volume":"32","author":"Denner","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.04.043_bib0265","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1073\/pnas.0903038106","article-title":"Fat-induced satiety factor oleoylethanolamide enhances memory consolidation","volume":"106","author":"Campolongo","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of United States of America"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813002519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813002519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T22:50:13Z","timestamp":1715295013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813002519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":53,"alternative-id":["S0166432813002519"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.04.043","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}